Karen Brorup Pedersen
Biographic Data
| ID | 9110312 |
|---|---|
| NAME | Karen Brorup Pedersen |
| GIVEN NAMES | Karen Brorup |
| FAMILY NAME | Pedersen |
| SIGNATURE | PEDERSEN K B |
| AFFILIATIONS | Amager Hospital |
| ORCID | 0000-0002-2501-8421 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Nucleoside/nucleotide reverse transcriptase inhibitor-associated weight gain in people living with HIV
Weight gain effects of Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in people with HIV (PWH) have been sparsely studied.Participants were enrolled in the Copenhagen Comorbidity in HIV Infection (COCOMO) study. PWH receiving a backbone of emtricitabine, or lamivudine combined with abacavir, tenofovir disoproxil, or tenofovir alafenamide were analysed. Weight gain according to ART backbone and to the third drug was analysed using a multip…
No prominent works on this page.
Nucleoside/nucleotide reverse transcriptase inhibitor-associated weight gain in people living with HIV
Weight gain effects of Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in people with HIV (PWH) have been sparsely studied.Participants were enrolled in the Copenhagen Comorbidity in HIV Infection (COCOMO) study. PWH receiving a backbone of emtricitabine, or lamivudine combined with abacavir, tenofovir disoproxil, or tenofovir alafenamide were analysed. Weight gain according to ART backbone and to the third drug was analysed using a multip…
Antiretroviral therapy (1 work) · Biology (1 work) · Comorbidity (1 work) · Gene (1 work) · Genetics (1 work) · HIV-related health complications and treatments (1 work) · Internal Medicine (1 work) · Medicine (1 work) · Nucleoside (1 work) · Nucleoside Reverse Transcriptase Inhibitor (1 work)